baber/WOPTO huggingface dataset:
Patent JP-3588130-B2 (JP)
IPC: A61N1/08
Filed: 1993-01-08
Granted: 2004-11-10
Abstract: A defibrillator/monitor (10) is disclosed employing a motion detection circuit 18 and control and processing circuit (20) that cooperatively detect motion at a patient-electrode interface. In that regard, an impedance measurement circuit (24) produces an output indicative of the impedance of the interface. This output is then processed by a number of filter elements before being analyzed by a motion detection routine (52). The motion detection routine includes subroutines (62 and 64) that compare the impedance against distinct upper and lower limits and then monitor the time at which the signal is above and below the limits. Basically, motion is indicated if the signal undergoes relatively large variations for a short time, or smaller variations for a longer time. A third motion clear subroutine (66) is used to determine when motion is no longer detected. Finally, a similar scheme (102) is employed to quickly restore the various filter elements after saturation. <IMAGE>   <IMAGE>
Patent JP-S6245820-B2 (JP)
IPC: B29D30/00
Filed: 1981-01-12
Abstract: A completed, shaped and uncured tire is off-loaded from the tire building machine on which the tire has been built by first engaging the completed tire coaxially within a ring having radially movable segments and then moving the ring with the tire coaxially off the building machine to a chucking device engageable with the inner peripheries of the respective bead portions of the tire. The ring is then expanded and moved coaxially from the tire and the chucking device now holding the tire is rotated to place the tire axis in vertical orientation and elevated to a position above the tire machine where the exterior surface of the tire is grasped by a pair of palms mounted on a swing arm. After the chucking device is moved downwardly clear of the tire, the tire is then moved horizontally by the swing arm and deposited on an overhead belt conveyor to be transported thereby to further processing. The tire building machine operator is relieved of the effort and time required for manual removal of the tire and the completed tire is protected from inadvertent damage due to manual handling. In particular, the tire is elevated from the operating floor in a convenient and expeditious manner.
Patent AU-685548-B2 (AU)
Title: Device for cleansing welding torches
Inventor: NILSSON VALTER
IPC: B23K9/12
Filed: 1994-10-26
Granted: 1998-01-22
Abstract: PCT No. PCT/SE94/01007 Sec. 371 Date Apr. 25, 1996 Sec. 102(e) Date Apr. 25, 1996 PCT Filed Oct. 26, 1994 PCT Pub. No. WO95/13162 PCT Pub. Date May 18, 1995The present invention relates to a device for automatically cleaning and curing off the wire in the nozzles of MIG/MAG welding equipment. It is characterized in that the device, which is portable, comprises a centering member (2) for insertion of a nozzle (1), and milling means (4, 5) to millcoated parts (6) of the nozzle, as well as possibly a cutting member (10) for the foremost part of the welding bead (7) of material applied, the milling means and cutting member if any (4, 5 and 10, respectively) being rotated by a drive means (3), designed to start automatically upon insertion of the nozzle (1).
Patent AU-597144-B2 (AU)
Title: Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
Inventor: KAPPAS ATTALLAH
IPC: A61P31/04
Filed: 1987-12-07
Granted: 1990-05-24
Abstract: Use of tin protoporphyrin and tin mesoporphyrin together with ultraviolet light in the treatment of psoriasis.
Patent AU-765802-B2 (AU)
Title: 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
Inventor: BRYANS JUSTIN STEPHEN
IPC: C07D291/00
Filed: 1998-11-10
Granted: 2003-10-02
Abstract: Novel amines of formulas 1, 1C, 1F, 1G and 1H <CHEM> or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, heterocycle, sulfonic acid, or hydroxamic acid; A' is a bridged ring selected from <CHEM> wherein is the point of attachment; Z1 to Z4 are each independently selected from hydrogen and methyl; o is an integer of from 1 to 4; and p is an integer of from 0 to 2. In formula (1) above R cannot be sulfonic acid when m is 2 and n is 1 are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders, especially irritable bowel syndrome.
Patent AU-750682-B2 (AU)
Title: Hydrofoil sail craft
Inventor: BOURN STEPHEN
IPC: B63H9/06
Filed: 1999-11-03
Granted: 2002-07-25
Abstract: A sailing craft including a single hydrofoil assembly, an aerofoil assembly, and a hull assembly with a rigid beam interconnecting the hydrofoil assembly, the aerofoil assembly, and the hull assembly. The hull is separate and displaced from the hydrofoil assembly and is, in use, supported above the water by the rigid beam. The hydrofoil assembly, the aerofoil assembly, and the hull assembly are preferably interconnected such that the hydrofoil assembly and the aerofoil assembly are disposed at opposite ends of the rigid beam and the hull is connected to the beam therebetween.
Patent AU-685582-B2 (AU)
Title: Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
Inventor: BAKER RAYMOND
IPC: A61P29/00
Filed: 1995-02-06
Granted: 1998-01-22
Abstract: PCT No. PCT/GB95/00228 Sec. 371 Date Sep. 26, 1996 Sec. 102(e) Date Sep. 26, 1996 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/21819 PCT Pub. Date Aug. 17, 1995   <IMAGE>  (I)  The present invention relates to compounds of formula (I) wherein n is 3 and where any carbon atom of (CH2)n may be substituted by R4 and/or R5; X represents O or S; R1 represents (CH2)qphenyl, wherein q is 0, 1 , 2 or 3 which may be optionally substituted in the phenyl ring; R2 represents aryl selected from phenyl and naphthyl; heteroaryl selected from indazolyl, thienyl, furyl, pyridyl, thiazolyl, tetrazolyl and quinolyl; benzhydryl; or benzyl; wherein each aryl or heteroaryl moiety may be substituted; R4 and R5 each independently represent H, halo, C1-6alkyl, oxo, CO2Ra or CONRaRb; R6 represents H or C1-6alkyl; R7 represents trifluoromethyl, C2-6alkenyl, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl, (CH2)pNR9R10, CO2R16, CONR9R10, (CH2)pCO2R16, (CH2)pCONR9R10, (CH2)pNR9COR16, (CH2)pNHSO2R11, (CH2)pOR16, (CH2)pOC(O)R9 or (CH2)pOC1-4alkylCOR17 or C1-6alkyl substituted by a hydroxy group; R8 repents H, CORa, CO2Ra, COCONRaRb, COCO2Ra, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl, C1-6alkyl optionally substituted by a group selected from (CO2Ra, CONRaRb, hydroxy, cyano, CORa, NRaRb, C(NOH)NRaRb, CONHphenyl(C1-4alkyl), COCO2Ra, CONHNRaRb, C(S)NRaRb, CONRaC1-6alkylR12, CONR13C2-6alkynyl, CONR13C2-6alkenyl, COCONRaRb, CONRaC(NRb)NRaRb, CONRaheteroaryl, and optionally substituted phenyl or C1-6alkyl, optionally substituted by oxo, substituted by an optionally substituted aromatic heterocycle; Ra and Rb each independently represent H, C1-6alkyl, trifluoromethyl or phenyl optionally substituted by C1-6alkyl, halo or trifluoromethyl. The compounds are of particular use in the treatment of pain, inflammation, migraine and emesis.
Patent AU-762480-B2 (AU)
Title: Chitosan metal complexes and method controlling microbial growth on plants using same
Inventor: BEN-SHALOM NOACH
IPC: A01N59/16
Filed: 1999-11-24
Granted: 2003-06-26
Abstract: A method for controlling bacterial and fungal diseases in plants which includes applying a chitosan metal chelate complex having at least two metal ion species to the plant. Chitosan metal complexes for application to control bacterial and fingal diseases in plants are also disclosed.
Patent AU-651715-B2 (AU)
Title: Pharmaceutical spheroid formulation
Inventor: BUXTON IAN RICHARD
IPC: A61K31/55
Filed: 1992-08-06
Granted: 1994-07-28
Abstract: A controlled release composition comprising spheroid cores consisting of diltiazem or a pharmaceutically acceptable salt thereof and optionally a spheronising agent, said cores being coated with a controlled release layer. The spheronising agent when present is preferably microcrystalline cellulose. Ethylcellulose is a preferred controlled release coating. The controlled release coating preferably contains a plasticiser, a surfactant and a tack-modifier.
Patent AU-775391-B2 (AU)
Title: Connective tissue growth factor fragments and methods and uses thereof
Inventor: GROTENDORST GARY R
IPC: A61K48/00
Filed: 1999-12-14
Granted: 2004-07-29
Abstract: The present invention is directed to CTGF fragments comprising at least exon 2 or exon 3 of CTGF and having the ability to induce extracellular matrix synthesis, in particular, collagen synthesis and myofibroblast differentiation. The present invention is further directed to methods using said CTGF fragments to identify compositions which modulate the activity of said CTGF fragments and to the compositions so identified. The invention also relates to methods of treating CTGF-associated disorders and diseases associated with the overproduction of the extracellular matrix.
Patent AU-684633-B2 (AU)
Title: Method for controlling configuration of laser induced breakdown and ablation
Inventor: MOUROU GERARD A
IPC: B23K26/40
Filed: 1995-03-29
Granted: 1997-12-18
Abstract: In one aspect the invention provides a method for laser induced breakdown of a material with a pulsed laser beam where the material is characterized by a relationship of fluence breakdown threshold (Fth) versus laser beam pulse width (T) that exhibits an abrupt, rapid, and distinct change or at least a clearly detectable and distinct change in slope at a predetermined laser pulse width value. The method comprises generating a beam of laser pulses in which each pulse has a pulse width equal to or less than the predetermined laser pulse width value. The beam is focused to a point at or beneath the surface of a material where laser induced breakdown is desired.The beam may be used in combination with a mask in the beam path. The beam or mask may be moved in the x, y, and Z directions to produce desired features. The technique can produce features smaller than the spot size and Rayleigh range due to enhanced damage threshold accuracy in the short pulse regime.
Patent AU-765880-B2 (AU)
Title: Viscous drag impeller components incorporated into pumps, turbines and transmissions
Inventor: DIAL DANIEL CHRISTOPHER
IPC: F04D5/00
Filed: 2000-12-20
Granted: 2003-10-02
Abstract: The present invention is for the efficient transfer of mechanical power through a fluid medium. The various embodiments of the present invention exploit the natural physical properties of fluids to create a more efficient means of driving fluids as well as transferring power from propelled fluids. The present invention employs an impeller assembly in a variety of applications including hydroelectric turbines, fluid turbines, turbine transmissions and pumps of various types. The multi-disk impeller assembly having a central cavity, a specialized central hub design and reinforcing backing plates contribute to greater efficiency and less turbulence, friction and noise.
Patent AU-783545-B2 (AU)
Title: Universal procedure for refolding recombinant proteins
Inventor: LIN XINLI
IPC: A61K39/00
Filed: 2000-12-28
Granted: 2005-11-10
Abstract: A universal folding method that has been demonstrated to be effective in refolding a variety of very different proteins expressed in bacteria as inclusion bodies has been developed. Representative proteins that can be dissolved and refolded in biologically active form, with the native structure, are shown in Table I. The method has two key steps to unfold and then refold the proteins expressed in the inclusion bodies. The first step is to raise the pH of the protein solution in the presence of denaturing agents to pH greater than 9, preferably 10. The protein solution may be maintained at the elevated pH for a period of up to about 24 hours, or the pH immediately decreased slowly, in increments of about 0.2 pH units/24 hours, until the solution reaches a pH of about 8.0, or both steps used. In the preferred embodiment, purified inclusion bodies are dissolved in 8 M urea, 0.1 M Tris, 1 mM glycine, 1 mM EDTA, 10 mM beta-mercaptoethanol, 10 mM dithiothreitol (DTT), 1 mM redued glutathion (GSH), 0.1 mM oxidized glutathion (GSSG), pH 10. The absorbance at 280 nm (OD280) of the protein solution is 5.0. This solution is rapidly diluted into 20 volumes of 20 mM Tris base. The resulting solutin is adjusted to pH 9.0 with 1 M HCl and is kept at 4° C. for 24 hr. The pH is adjusted to pH 8.8 and the solution is kept at 4° C. for another 24 hrs. This process is repeated until the pH is adjusted to 8.0. After 24 hr at pH 8.0, the refolded proteins can be concentrated by ultrafiltration and applied to a gel filtration column for purification.
Patent AU-745620-B2 (AU)
Title: Evaporative light scattering device
Inventor: BENEDICT BART C
IPC: G01N30/84
Filed: 2001-03-05
Granted: 2002-03-28
Abstract: The present invention is directed to a device for evaporative light scattering detection that can be used for a wide range of sample types and mobile phases. The device may be quickly converted between a single flow and a split flow configuration through the use of a retractable impactor (105). The drift tube (104) of the device is in flow communication with the nebulizer (102) of the device, the drift tube (104) comprising a drain outlet (110) and the retractable impactor (105) positioned downstream in the direction of flow from the nebulizer (102).
Patent AU-564635-B2 (AU)
Title: Production of vinyl chloride - ethylene terpolymese
Inventor: BALL PETER
IPC: C08F214/06
Filed: 1984-04-04
Granted: 1987-08-20
Abstract: A process for the preparation of finely-divided aqueous copolymer dispersions with a solids content of 10 to 70% by weight, based on the dispersion, comprising emulsion polymerizing (a) 1 to 50% by weight of ethylene and (b) 99 to 50% by weight of at least two ethylenically unsaturated comonomers in the presence of a free-radial initiator and at least one member of the group consisting of emulsifier and a protective colloid and optionally present conventional adjuvants, the ethylenically unsaturataed comonomers being (b1) 79.5 to 99.5% by weight of vinyl chloride, (b2) 0 to 15% by weight of ethylenically unsaturated oil-soluble monomers, (b3) 0.5 to 10% by weight of ethylenically unsaturated, functional, water-soluble monomers and (b4) 0 to 5% by weight of oil-soluble monomers monoethylenically unsaturated and containing functional groups or polyethylenically unsaturated and mixtures thereof with the proviso that the monomers of (b2) and (b4) are copolymerizable with (a) and (b1), the comonomers being initially present in 1 to 40% by weight and the content of the water-soluble monomers being 1 to 35% by weight of the comonomers phase initially present and the rest of component (b) being added as an aqueous emulsion during polymerization and the polymerization is effected at 0 DEG  to 120 DEG  C. with an ethylene pressure of 10 to 150 bar which is built up at the latest by the point in time at which polymerization of the initial material is complete.
Patent AU-755764-B2 (AU)
Title: Meat color imaging system for palatability and yield prediction
Inventor: BELK KEITH E
IPC: A22B5/00
Filed: 1999-02-18
Granted: 2002-12-19
Abstract: An image analysis (IA) system for scoring characteristics predictive of palatability and yield of a meat animal carcass or cut. The IA system uses an imaging device, a data processing unit for processing image data, and an output device for output of processed data to the user. Also disclosed is a method for using the IA system in predicting palatability, yield, or defect conditions of a meat animal carcass or cut. The results are identified with a particular piece of meat for further grading, sortation and processing.
Patent AU-667334-B2 (AU)
Title: 5-O-desosaminylerythronolide derivatives
Inventor: ASAKA TOSHIFUMI
IPC: C07H17/08
Filed: 1992-12-25
Granted: 1996-03-21
Abstract: A 3-(substituted carbonyloxy)-5-O-desosaminylerythronolide derivative represented by general formula (I), which is useful as a novel macrolide antibiotic with a potent antibacterial power, wherein R' and R'' represent each hydrogen or acyl; Y represents optionally substituted alkylene, ether linkage, acid linkage or vinylene; R represents hydrogen, optionally substituted alkyl, aryl or heteroaryl; and -A- represents an erythronolide moiety (wherein the 9-position may be an imino ether group and the 11- and 12-positions may be involved in the formation of a heterocycle such as a cyclic carbonate group) or a 9-azahomoerythronolide moiety. <CHEM>
Patent AU-698477-B2 (AU)
Title: Wound drainage equipment
Inventor: LINA CESAR Z
IPC: A61M1/00
Filed: 1995-08-21
Granted: 1998-10-29
Abstract: The appts. includes a porous pad which is permeable to fluids for introduction onto a wound. A dressing covers the wound and provides an air-tight seal around the wound. A drainage tube connects the pad to a suction pump so that negative pressure can be applied to the wound to draw fluids from the wound. The tube is connected to the pump via a canister for collecting fluids sucked from the wound. At least one filter is interposed between the canister and the pump. The filter is located in the canister which is removably attached to a housing for the pump. The canister is removably received in a recess in the housing. A detector determines when the canister is full of fluid by sensing change of capacitance as the canister fills up. The pad is a polymer foam with interconnecting cells.
Patent AU-656848-B2 (AU)
Title: Method and apparatus to detect coagulation
Inventor: BACH DAVID T
IPC: G01N35/02
Filed: 1993-01-22
Granted: 1995-02-16
Abstract: The present invention relates to an apparatus for randomly detecting blood coagulation in a sample. The apparatus includes a reaction container wheel (2), a sampling station (6), a reaction container transfer means for transferring the reaction containers to a reaction wheel (14), a driving means for continuously indexing the reaction wheel (14), a plurality of reagent addition means positioned along the reaction wheel to allow for a complete incubation, without changing the rate of indexing of the reaction wheel, prior to detection and a plurality of detection means (48) are positioned along the reaction wheel to detect the rate of reaction without changing the rate of indexing of the reaction wheel. The apparatus is used to detect blood coagulation in a sample.
Patent AU-703618-B2 (AU)
Title: Medicament carrier for dry powder inhalator and process for forming the same
Inventor: OORT MICHIEL M VAN
IPC: A61M15/00
Filed: 1995-10-19
Granted: 1999-03-25
Abstract: A medicament carrier for use in a dry powder inhalator device and a process for forming the same wherein the medicament carrier has at least one carrier screen portion. The carrier screen portion defines a plurality of interstices therein and carries a powdered medicament which may be applied in a suspension and the suspending agent then evaporated off and which is loaded onto the carrier screen portion surface such that the interstices of the carrier screen portion are at least partially open and free of the dry powdered medicament. <IMAGE>
Patent AU-636572-B2 (AU)
Title: Gene replacement as a tool for the construction of aspergillus strains
IPC: C12N15/31
Filed: 1989-08-16
Granted: 1993-05-06
Abstract: Transformation of Aspergillus, particularly A. niger is demonstrated. Integration at the glucoamylase locus is exemplified. A chymosin expression construct is inserted at a locus, where the chymosin may be joined to a signal sequence for efficient secretion.
Patent AU-732845-B2 (AU)
Title: Pesticidal agents
Inventor: JARRETT PAUL
IPC: A01N63/20
Filed: 1997-08-27
Granted: 2001-05-03
Abstract: A method for killing pests (e.g. insects) comprising administering material from Xenorhabdus species (e.g. X. nematophilus) such as cells or supernatants orally to the pests, either alone or in conjunction with Bacillus thuringiensis or pesticidal materials derived therefrom. Also disclosed is an isolated pesticidal agent (and compositions comprising the same) characterized in that it is obtainable from cultures of X. nematophilus or mutants thereof, has oral pesticidal activity agent Pieris brassicae, Pieris rapae and Plutella xylostella, is substantially heat stable to 55° C., is proteinaceous, acts synergistically with B. thuringiensis cells as an oral pesticide and is substantially resistant to proteolysis by trypsin and proteinase K. DNA encoding pesticidal activity is also disclosed.
Patent AU-763469-B2 (AU)
Title: Process and agent for the sanitization of contaminations caused by viruses
Inventor: BERNHARDT DIETER
IPC: A01N31/16
Filed: 1999-07-28
Granted: 2003-07-24
Abstract: Sanitization of virus-contaminated tissues, cell cultures, blood, plasma, blood or plasma fractions and materials and equipment used in virology comprising using a solution of a phenol or phenyl ether (I) with one or two saturated or unsaturated hydrocarbon substituents, each containing up to 4 carbon atoms, is new.  An Independent claim is also included for a composition for sanitizing tissues or cell cultures or materials and equipment used in virology, comprising a solution of (I).
Patent AU-583507-B2 (AU)
Title: Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
Inventor: LEE PING I
IPC: A61K9/22
Filed: 1985-05-09
Granted: 1989-05-04
Abstract: An active agent containing controlled release diffusion jevice comprising a swellable hydrogel matrix in the non-swollen state, interpenetrated with an active agent solute laving a stable concentration distribution increasing in a gradient normal to the surface of the device and between the surface and the core thereof, said gradient being in the form of a substantially continuous, inflection point containing, sigmoidal curve, such that the device, when placed in an aqueous hydrogel swelling environment, releases said active agent in a controlled continuous manner by diffusion for a predetermined period of time, a method of preparing such a device, and the use thereof to release an active agent into the intended environment of use.
Patent AU-755175-B2 (AU)
Title: Non-yellowing para-tertiary-alkyl phenyl substituted triazine ultraviolet light absorbers
Inventor: GUPTA RAM B
IPC: C07D/
Filed: 1999-06-18
Granted: 2002-12-05
Abstract: This invention relates generally to para-tertiary alkyl phenyl substituted pyrimidines and triazines and the use thereof to protect against degradation by environmental forces, inclusive of ultraviolet light, actinic radiation, oxidation, moisture, atmospheric pollutants and combinations thereof. The new class of para-tertiary alkyl phenyl substituted pyrimidines and triazines includes two tertiary alkylated phenyl groups, and a resorcinol or substituted resorcinol group attached to the triazine or pyrimidine ring. These materials may, under the appropriate circumstances, be bonded to formulations comprising coatings, polymers, resins, organic compounds and the like via reaction of the bondable functionality with the materials of the formulation. A method for stabilizing a material by incorporating such para-tertiary alkyl phenyl substituted pyrimidines and triazines is also disclosed.